2,4-dinitrophenol (DNP)

a historically effective weight-loss poison that uncouples mitochondrial energy production, can drive uncontrollable hyperthermia and cardiovascular collapse, and has no established antidote.

tier F · weight loss · F site tier because effective weight loss does not justify lethal uncoupling risk

verdict

DNP can reduce weight, and that efficacy is exactly why the safety verdict must be unambiguous: the mechanism has killed people and offers no controllable clinical margin for this use.

if you're asking whether DNP works for weight loss — yes, historical human reports document increased metabolic rate and weight loss. efficacy does not rescue the risk calculation. the same uncoupling that burns more fuel can accelerate heat production and ATP failure beyond control.

if you're asking whether careful temperature monitoring makes it safe — no. blood concentrations, delayed absorption, product variability, and continued intracellular uncoupling make external temperature an incomplete and late signal. serious deterioration can continue after the last exposure.

if you're asking whether there is an antidote — there is no established antidote that reverses mitochondrial uncoupling. treatment is emergency supportive care, aggressive cooling, and management of complications. suspected exposure is an emergency, not a self-monitoring problem.

if you're asking what its half-life is — the site publishes no normal-use half-life. human values come from poisoned patients and vary with severe toxicity and delayed absorption, while the animal paper used a two-compartment model without a defensible single parent half-life for this surface.

If exposure is suspected, emergency services and poison control are the relevant resources. This page does not provide use or rescue instructions.

why F-tier

F-tier is mandatory under the site's safety rule. DNP has real historical human weight-loss efficacy, so this is not a failed-drug grade. Its mechanism can produce uncontrolled hyperthermia, convulsions, acute kidney injury, cardiovascular collapse, and death, with no established antidote and no defensible consumer safety margin. Outcome efficacy remains visible as B so the warning is honest rather than dismissive.

the core tension

DNP's weight-loss outcome is not disputed. The impossible trade is that efficacy and lethality arise from the same uncontrolled mitochondrial mechanism, with no established antidote and no reliable consumer safety margin.

what it is

2,4-Dinitrophenol is a 184.11 Da nitrophenol, C6H4N2O5, CAS 51-28-5. It is an industrial chemical and mitochondrial protonophore with a brief, disastrous history as a weight-loss agent. It is not an approved medicine and is not a peptide.

what it does

DNP shuttles protons across the inner mitochondrial membrane. Oxidative fuel use continues, but less of the proton gradient is captured as ATP and more energy is released as heat. Metabolic rate can rise sharply. There is no receptor off-switch, and rising temperature can further accelerate metabolism into a self-amplifying emergency.

origin

Human weight-loss use expanded in the early 1930s after clinical reports of increased metabolic rate and rapid weight loss. Reports of cataracts, agranulocytosis, neuropathy, liver and kidney injury, hyperthermia, and death ended its medical weight-loss era. Modern internet sales repeatedly recreate the same poisoning pattern.

why researchers are interested

DNP does not rely on appetite suppression and can produce visible weight change quickly. That effectiveness creates the trap. Users interpret a strong physiological effect as evidence that exposure can be managed, while toxicology shows a mechanism whose severity is difficult to predict and difficult to stop.

does it work

It can produce weight loss. The outcome cell is B for historical human efficacy, while the compound remains F overall because the safety record is decisive.

claims vs the data

• DNP causes weight loss — supported — historical human reports document increased metabolic rate and weight loss.
• a careful dose makes DNP safe — contradicted — fatal and severe toxicity, individual variability, product uncertainty, delayed deterioration, and no antidote defeat a reliable self-managed margin.
• temperature monitoring prevents severe poisoning — unsupported — temperature can be a late and incomplete signal while intracellular uncoupling and toxicity continue.
• DNP has a simple half-life that predicts when danger is over — contradicted — poisoned-patient kinetics are variable and absorption may be delayed; clinical deterioration can outlast a simplistic elimination estimate.

key facts

• molecular formula: C6H4N2O5
• molecular weight: 184.11 g/mol
• amino acids: n/a (small molecule, not a peptide)
• half-life: not structured; poisoned-patient estimates and animal two-compartment disposition are not a normal-use human PK value
• type: toxic mitochondrial protonophore and oxidative-phosphorylation uncoupler
• CAS: 51-28-5
• no established antidote that reverses uncoupling
• 1930s human efficacy and severe-toxicity record
• 0 approved weight-loss indications
• F overall tier despite a B efficacy outcome

frequently asked questions

Does DNP cause weight loss?

Yes. Historical human use increased metabolic rate and reduced weight. That effect came with cataracts, neuropathy, organ injury, severe hyperthermia, and deaths, which is why efficacy does not make it acceptable.

Why is DNP dangerous?

It uncouples mitochondrial fuel oxidation from ATP production. Energy is dissipated as heat, ATP supply is impaired, and escalating temperature can accelerate the crisis.

Is there a safe dose of DNP?

No safe human weight-loss exposure is established. Product variability and large individual differences make historical amounts especially unsafe to reinterpret as a range.

Is there an antidote for DNP poisoning?

No established antidote directly reverses uncoupling. Suspected exposure requires immediate emergency and poison-control involvement.

What is DNP's half-life?

No routine-use number is published here. Poisoned-patient estimates are highly variable and clinically distorted, and the animal disposition paper does not support a single transferable parent half-life.

related peptides

• BAM15 — a preclinical uncoupler developed for a wider animal safety window, with no human exposure data
• semaglutide — an approved obesity medicine with controlled human outcomes and safety monitoring
• tirzepatide — an approval-grade weight-loss comparator

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.